Filing Details

Accession Number:
0001567619-19-017607
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-27 17:23:12
Reporting Period:
2019-08-27
Accepted Time:
2019-08-27 17:23:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505497 Biorestorative Therapies Inc. BRTX Services-Misc Health & Allied Services, Nec (8090) 911835664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1756228 Lance Alstodt C/O Biorestorative Therapies, Inc.
40 Marcus Drive, Suite 1
Melville NY 11747
Evp And Chief Strategy Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-27 100 $0.26 10,100 No 4 P Direct
Common Stock Acquisiton 2019-08-27 3,700 $0.27 13,800 No 4 P Direct
Common Stock Acquisiton 2019-08-27 6,200 $0.28 20,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $0.75 2028-10-15 500,000 500,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-10-15 500,000 500,000 Direct
Footnotes
  1. The option vests to the extent of 100,000 shares as of October 15, 2018, 150,000 shares upon the earlier of October 15, 2019 or the date on which the initial patient recruitment for the Company's Phase II lumbar clinical trial occurs, and 250,000 shares as of October 15, 2020.